CHAD BARNETT: Open Payments
NPI 1912103615 · RIVERTON, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,659 in 94 payments from 29 companies in 2025. Trend: 2023 $67 · 2024 $242 · 2025 $1,659
Food & beverage: $1,659
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $329 |
| TerSera Therapeutics LLC | 7 | $204 |
| Lilly USA, LLC | 8 | $128 |
| Corcept Therapeutics | 4 | $96 |
| CSL Behring | 3 | $90 |
| Amgen Inc. | 5 | $76 |
| Tris Pharma Inc | 4 | $74 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $74 |
| AstraZeneca Pharmaceuticals LP | 4 | $62 |
| Lundbeck LLC | 3 | $60 |
Products named: Quzyttir, VRAYLAR, Korlym, MOUNJARO, Dyanavel XR, CAPLYTA, UBRELVY, Hizentra.
Industry payments across UT — which companies pay providers there.
